LONDON, United Kingdom — Albumin was no more effective than saline control and was associated with more adverse effects in the treatment of patients with acute stroke in a phase 3 study. The results, ...
Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results